Kintsugitx

Barcelona, ES · 1 known investors

Kintsugi Therapeutics is a preclinical-stage biopharmaceutical company developing first-in-class endoplasmic reticulum stress inhibitors for treating non-alcoholic steatohepatitis and other liver conditions.

BiotechMedical Devices